Skip to main content
Top
Gepubliceerd in:
Omslag van het boek

2016 | OriginalPaper | Hoofdstuk

214 Schimmelinfectie van de nagel/onychomycose

Auteur : L.H. van Berkel

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Een onychomycose of schimmelinfectie van de nagel (‘kalknagel’) is de meest voorkomende aandoening van de nagel.1 Het is een infectie aan een of meer nagels door schimmels of gisten van het nagelbed, die een karakteristieke geel-witte verkleuring van de nagelplaat geeft met distale loslating van de nagel, subunguale hyperkeratose of totale nageldystrofie.2
Literatuur
1.
go back to reference Saunte DML, Holgersen JB, Aedersdal MH, Strauss G, Bitsch M, Svendsen OL, et al. Prevalence of toenail onychomycosis in diabetic patients. Acta Derm Venerol 2006;86:425-8.CrossRefPubMed Saunte DML, Holgersen JB, Aedersdal MH, Strauss G, Bitsch M, Svendsen OL, et al. Prevalence of toenail onychomycosis in diabetic patients. Acta Derm Venerol 2006;86:425-8.CrossRefPubMed
2.
go back to reference Van Puijenbroek EP, Duyvendak RJP, De Kock CA, Krol SJ, Jaspar AHJ, Loogman MCM. NHG-Standaard Dermatomycosen (Eerste herziening). Huisarts Wet 2008;51:76-84.CrossRef Van Puijenbroek EP, Duyvendak RJP, De Kock CA, Krol SJ, Jaspar AHJ, Loogman MCM. NHG-Standaard Dermatomycosen (Eerste herziening). Huisarts Wet 2008;51:76-84.CrossRef
3.
go back to reference Crawford F, Ferrari J. Fungal nail infections. Clin Evid 2005;:2036-43. Crawford F, Ferrari J. Fungal nail infections. Clin Evid 2005;:2036-43.
4.
go back to reference Burzykowski T, Molenberghs G, Abeck D, Haneke E, Hay R, Katsambas A, et al. High prevalence of foot diseases in Europe: results of the Achilles Project. Mycoses 2003;46:496-505.CrossRefPubMed Burzykowski T, Molenberghs G, Abeck D, Haneke E, Hay R, Katsambas A, et al. High prevalence of foot diseases in Europe: results of the Achilles Project. Mycoses 2003;46:496-505.CrossRefPubMed
5.
go back to reference Bell-Syer S, Porthouse J, Bigby M. Oral treatments for onychomycosis. Cochrane Database Syst Rev 2004;(2):CD004766. Bell-Syer S, Porthouse J, Bigby M. Oral treatments for onychomycosis. Cochrane Database Syst Rev 2004;(2):CD004766.
6.
go back to reference ’t Jong GW, Stricker BHCh, Sturkenboom MCJM. Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. BMJ 2004;328;931.CrossRefPubMedPubMedCentral ’t Jong GW, Stricker BHCh, Sturkenboom MCJM. Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. BMJ 2004;328;931.CrossRefPubMedPubMedCentral
7.
go back to reference Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acd Dermatol 2003;49:193-7.CrossRef Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acd Dermatol 2003;49:193-7.CrossRef
8.
go back to reference De Kock CA, Sampers GHMA, Knottnerus JA. Diagnosis and management of cases of suspected dermatomycosis in the Netherlands: influence of general practice based potassium hydroxide testing. Br. J Gen Pract 1995;45:349-51.PubMedPubMedCentral De Kock CA, Sampers GHMA, Knottnerus JA. Diagnosis and management of cases of suspected dermatomycosis in the Netherlands: influence of general practice based potassium hydroxide testing. Br. J Gen Pract 1995;45:349-51.PubMedPubMedCentral
9.
go back to reference Lousbergh D, Buntinx F, Piérard G. Diagnosing dermatomycosis in general practice. Fam Pract 1999;16:611-5.CrossRefPubMed Lousbergh D, Buntinx F, Piérard G. Diagnosing dermatomycosis in general practice. Fam Pract 1999;16:611-5.CrossRefPubMed
11.
go back to reference Warshaw EM, St Clair KR. Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. J Am Acad Dermatol 2005;53:717-20.CrossRefPubMed Warshaw EM, St Clair KR. Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. J Am Acad Dermatol 2005;53:717-20.CrossRefPubMed
12.
go back to reference Gupta AK, Paquet M, Simpson F, Tavakkol A.Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol 2012 May 28 [Epub ahead of print]. Gupta AK, Paquet M, Simpson F, Tavakkol A.Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol 2012 May 28 [Epub ahead of print].
13.
go back to reference Warshaw EM, St Clair KR. Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. J Am Acad Dermatol 2005;53:717-20.CrossRefPubMed Warshaw EM, St Clair KR. Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. J Am Acad Dermatol 2005;53:717-20.CrossRefPubMed
Metagegevens
Titel
214 Schimmelinfectie van de nagel/onychomycose
Auteur
L.H. van Berkel
Copyright
2016
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-1386-0_214